Pfizer faces another year of revenue decline in 2026, as Covid and loss-of-exclusivity headwinds weigh on top line growth.

For anyone dreading sitting across from their teenage cousin and feeling like the oldest person to ever walk the earth as families gather over the next few weeks for the holidays, this one is for you.

If they pull it off successfully, higher inflation may not be a problem if it results in much more broad-based economic ...

Past returns often dominate mutual fund discussions, but they don’t tell the full story. Understanding risk, consistency and ...

Teva Pharmaceutical (TEVA) is trading at new 5-year highs. ・Shares are up more than 40% over the past year. ・The stock has ...

According to Benzinga Pro, ReAlpha Tech Corp's peer group average for short interest as a percentage of float is 4.02%, which ...

Santander (SAN) has strong technical momentum and is trading at new 10-year highs. ・SAN is up more than 160% in the past 52 ...

One of the most detailed 3D maps of how the human chromosomes are organized and folded within a cell's nucleus is published ...

Three of the top three camera rentals of the year have just been replaced at the very end of 2025: the Canon EOS R6 Mark III to replace the R6 Mark II, and the Sony A7 Mark V, which is the successor ...

Because the fund primarily invests in short-term bonds, which are much less volatile than longer-term bonds, it generally has a lower risk component. The fund is currently investing in a higher than ...

The grace period is over. Twelve predictions on where AI creates value, breaks assumptions and triggers backlash as 2026 ...

When thinking of jobs artificial intelligence could be replacing, that of teaching is probably not at the top of the list.